Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
PYXS | Pyxis Oncology, Inc. | Director | $352K | Mar 26, 2024 | ||
PLRX | PLIANT THERAPEUTICS, INC. | Director | $55.7K | Jun 13, 2024 | ||
GWPH | GW PHARMACEUTICALS PLC | U.S. Chief Commercial Officer | May 5, 2021 | |||
IMPL | IPI Legacy Liquidation Co | Director | Jun 16, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|